Sign in
Taking peoplePhase 2

A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile Dysfunction

Key facts

Who runs it
Ryan Flannigan, MD
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
83 people, planned
Started
May 2026
Expected to end
May 2027
Type of study
Interventional
Treatments tested
  • ST-04
Record updated
22 May 2026

Who can take part

Age
21 years to 75 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Have had a confirmed clinical diagnosis of ED for more than three months based upon IIEF
  • Have failed PDE5 inhibitor therapy (inability to achieve an erection with adequate rigidity to allow penetrative sex)
  • Ability to take oral medication (sildenafil) and be willing to adhere to the study intervention regimen
  • Engaged in heterosexual relationship with partner for a minimum of 6 months

Who cannot take part

  • History of myocardial infarction, stroke, or life-threatening arrhythmia within 6 months prior to enrollment into the study
  • Use of oral, topical or sublingual nitrates within 3 months prior to enrollment into the study
  • Inadequate response to intracavernosal injection therapy previously
  • History of unstable medical or psychiatric condition that, in the opinion of the principal investigator, could impact the patient's ability to complete the study investigations or protocol
  • Cardiovascular conditions that prevent sexual activity (NYHA Class II or higher, any angina, or uncontrolled CHF or severe coronary artery disease)
  • Peyronie's disease or Meatal stenosis
  • Hepatic (Child-Pugh Class C) or renal failure (eGFR < 30)
  • Spinal cord injury, or penile anatomical abnormalities
  • Use of anti-androgens, or oral or injectable androgens
  • Documented hypotension or known orthostatic hypotension

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 21 and 75 years old?

This trial is currently available in Canada.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a single arm dose escalation trial of a mucoadhesive intraurethral polymer suspension of alprostadil (ST-04) and will investigate the efficacy of 3 dose levels of ST-04 in adult males with a clinical diagnosis of Erectile Dysfunction (ED). This study aims to determine if ST-04, with or without sildenafil, will improve erectile function (EF) compared to baseline.

Read full original descriptionShow less

Participants in this study will receive ST-04, a new formulation containing the vasodilator, alprostadil which is known to be an effective drug in treating erectile dysfunction. ST-04 will be dispersed along the urethra, forming a hydrogel which adheres to the lining of the urethra with the goal of penile tumescence and erection. Participants may receive up to 3 dose level escalations of ST-04 over a 12-week period, for a total of up to 11 administrations of ST-04. Dose escalation may also be done with and without sildenafil.

The group in the trial

  • Single-Arm Dose EscalationTreatment being tested

    Dose Level 1 is 500 μg of ST-04; Dose Level 2 is 1000 μg of ST-04 with or without Sildenafil; Dose Level 3 is 1500 μg of ST-04 with or without Sildenafil.

    Treatment: ST-04

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Phase 2 Clinical Trial of ST-04 Intraurethral Paste for Erectile Dysfunction
Criteria questions
Built from NCT07601646, who can take part
Record updated
22 May 2026